View Press Releases

PHARMASEAL and Viedoc Announce a Technical Integration Partnership

July 1, 2025

Nottingham, UK – [July 2, 2025] — PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.

Together, PHARMASEAL and Viedoc offer life sciences organizations a unified, cloud-based ecosystem to simplify trial oversight, accelerate study timelines, and improve data quality while ensuring regulatory compliance and operational efficiency.

“Our partnership with Viedoc brings together data management and clinical operational technologies that offer customers a choice of selecting the best-of-breed solutions for their clinical trials. By integrating these complementary technologies, both process and data interoperability is increased, which improves the overall execution of clinical trials” said Daljit Cheema, CEO of PHARMASEAL. “Our philosophy of providing a wider ecosystem of collaborative applications that can be supported by more inclusive partnerships and supported by strong open integrations is what the industry needs to prevent “lock in” to only a few vendor monopolies”.

The Engility® trial management platform provides a modern, cloud-based CTMS designed to manage the complexity of global studies. Engility empowers sponsors and CROs to optimize their clinical operations from study startup through closeout. Integrating Viedoc’s EDC technology provides seamless data flow between study planning, execution, and monitoring, reducing silos and manual reconciliation.

“We’re pleased to welcome PHARMASEAL to Viedoc Verified, our official partner program recognizing trusted collaborators in clinical trial technology,” said Bob Egner, CPO at Viedoc. “Our customers are seeking greater interoperability across their clinical systems to streamline operations and improve outcomes. Our collaboration with PHARMASEAL directly supports that need enabling a truly connected eClinical experience through seamless integration of CTMS and EDC. This partnership reflects our shared commitment to empowering sponsors, CROs, and sites with intuitive, future-ready solutions.”

Life science organizations can now take advantage of this combined solution to reduce system complexity, enhance data integrity, and shorten time to insight delivering higher quality outcomes for trials that support human health.

To learn more about the partnership and request a demo, visit www.pharmaseal.co or contact info@pharmaseal.co

About PHARMASEAL PHARMASEAL International Ltd, established in 2016, was founded with a vision to create a unified trial management platform that supports global life science organizations in managing clinical trials aimed at improving human health. The company’s team of clinical technology experts designed and developed the Engility® Trial Management platform to alleviate the burdens of clinical operations, enhance collaboration and oversight, and provide a unified suite that boosts clinical operations productivity. The Engility platform is engineered on a modern cloud architecture and designed to scale efficiently for all types of trials.

About Viedoc Viedoc Technologies designs engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We accomplish this by combining technology and creative design to streamline, automate, and simplify conventional processes within clinical research. Founded in 2003, Viedoc Technologies has become a leader in Electronic Data Capture (EDC), offering full support for decentralized clinical trials, unrivaled setup times, high-level security measures, and global support. www.viedoc.com